Coralville, IA, United States of America

Max Baker

This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Tansna Therapeutics, Inc.. Active years: 2017.

USPTO Granted Patents = 1 

Average Co-Inventor Count = 4.0

ph-index = 1

Forward Citations = 2(Granted Patents)


Company Filing History:


Years Active: 2017

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Max Baker - Innovator in Neurological Treatments

Introduction

Max Baker is a notable inventor based in Coralville, IA (US). He has made significant contributions to the field of pharmaceuticals, particularly in the treatment of neurological conditions. His innovative work has led to the development of compounds that hold promise for patients suffering from various neurological disorders.

Latest Patents

Max Baker holds 1 patent for his invention of 2,5-dialkyl-4-H/halo/ether-phenol compounds. This patent provides phenolic compounds that are useful in treating neurological conditions such as convulsions and tremors. The compounds are characterized by a specific structure, as detailed in the patent description, and include pharmaceutical compositions that comprise at least one of these compounds.

Career Highlights

Max Baker is currently associated with Tansna Therapeutics, Inc., where he continues to work on innovative solutions for neurological treatments. His dedication to research and development has positioned him as a key player in the pharmaceutical industry.

Collaborations

Throughout his career, Max has collaborated with talented individuals such as Eduardo J Martinez and Rajesh Kumar Mishra. These collaborations have further enhanced his research and contributed to the advancement of his projects.

Conclusion

Max Baker's contributions to the field of neurological treatments through his innovative compounds demonstrate his commitment to improving patient outcomes. His work continues to inspire advancements in pharmaceutical research and development.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…